Search

everythinglearnresearchcommunity

for

Search:↓

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Lokivetmab reduced itching in a dog with skin lymphoma.

High LGR5 levels in glioblastoma indicate poor prognosis and are essential for cancer stem cell survival.

PLD is an effective and safer alternative for treating breast cancer.

Finasteride improved reflexes and motor activity in rats with liver-related brain issues.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Sustained-release sodium valproate is effective in treating epilepsy, with some side effects influenced by genetics.

Letrozole reduces seizures but not brain damage in mice.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Valproic acid is a more effective treatment for vomiting in Alexander disease than other medications, with few side effects.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Suppressing ODC activity reduces tumor growth in hair follicles.

Wedelolactone may help treat chronic diseases by acting as an antioxidant and affecting important proteins.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Biotin mega-dose therapy led to dramatic improvement in a newborn with a rare metabolic disorder.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Stopping heptaminol medication reversed hair color loss in a patient on dialysis.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Early treatment with the right dose of stem cells can reduce lupus symptoms.

Sodium valproate can cause low platelets and hair loss.